1. Xiaoaiping injection enhances paclitaxel efficacy in ovarian cancer via pregnane X receptor and its downstream molecules
    Xiang-Qi Zhang et al, 2020, Journal of Ethnopharmacology CrossRef
  2. A broad analysis in clinical and in vitro models on regulator of G‐protein signalling 10 regulation that is associated with ovarian cancer progression and chemoresistance
    Burak Kucuk et al, 2021, Cell Biochemistry and Function CrossRef
  3. Long Noncoding RNA LINC01554 as a Novel Biomarker for Diagnosis and Prognosis Prediction of Epithelial Ovarian Cancer
    Ting Luo et al, 2021, Disease Markers CrossRef
  4. Ovarian Cancer: Treatment and Resistance to Pharmacotherapy
    David Lukanović et al, 2022, Reproductive Medicine CrossRef
  5. Ovarian Cancer Stem Cells: Approach to Individualized Medicine
    Nataša Kenda Šuster, 2022, Stem Cells in Reproductive Tissues and Organs CrossRef
  6. A tRNA fragment, tRF5-Glu, regulates BCAR3 expression and proliferation in ovarian cancer cells
    Kun Zhou et al, 2017, Oncotarget CrossRef
  7. Purified Tea (Camellia sinensis (L.) Kuntze) Flower Saponins Induce the p53-Dependent Intrinsic Apoptosis of Cisplatin-Resistant Ovarian Cancer Cells
    Ning Ren et al, 2020, International Journal of Molecular Sciences CrossRef
  8. Global scenario on ovarian cancer – Its dynamics, relative survival, treatment, and epidemiology
    Saba Shabir et al, 2020, Adesh University Journal of Medical Sciences & Research CrossRef
  9. Novel Therapeutic Strategies for Ovarian Cancer Stem Cells
    Nastassja Terraneo et al, 2020, Frontiers in Oncology CrossRef
  10. Expression of protein disulfide isomerase family members correlates with tumor progression and patient survival in ovarian cancer
    Soma Samanta et al, 2017, Oncotarget CrossRef
  11. Emerging Therapeutics to Overcome Chemoresistance in Epithelial Ovarian Cancer: A Mini-Review
    Robert Cornelison et al, 2017, International Journal of Molecular Sciences CrossRef
  12. Suppression of the ABCA1 Cholesterol Transporter Impairs the Growth and Migration of Epithelial Ovarian Cancer
    Jixuan Gao et al, 2022, Cancers CrossRef
  13. Significant relationship between the LAT1 expression pattern and chemoresistance in ovarian clear cell carcinoma
    Kimiya Sato et al, 2019, Virchows Archiv CrossRef
  14. Chemoresistance in Ovarian Cancer: Prospects for New Drugs
    Shivani Tendulkar et al, 2021, Anti-Cancer Agents in Medicinal Chemistry CrossRef
  15. Potentials of MicroRNA in Early Detection of Ovarian Cancer by Analytical Electrical Biosensors
    N. A. Parmin et al, 2022, Critical Reviews in Analytical Chemistry CrossRef
  16. AS1411 aptamer-decorated cisplatin-loaded poly(lactic- co -glycolic acid) Nanoparticles for Targeted Therapy of miR-21-inhibited Ovarian Cancer Cells
    Somayeh Vandghanooni et al, 2018, Nanomedicine CrossRef
  17. miR-21 Induces Chemoresistance in Ovarian Cancer Cells via Mediating the Expression and Interaction of CD44v6 and P-gp
    Yanqing Wang et al, 2021, OncoTargets and Therapy CrossRef
  18. Anti-proliferative effect and cell cycle arrest induced by saponins extracted from tea (Camellia sinensis) flower in human ovarian cancer cells
    Yaomin Wang et al, 2017, Journal of Functional Foods CrossRef
  19. Different Prognostic Implications of Aquaporin-1 and Aquaporin-5 Expression among Different Histological Types of Ovarian Carcinoma
    Kimiya Sato et al, 2020, Pathology & Oncology Research CrossRef
  20. Evaluation of Beta-Catenin Subcellular Localization and Water Channel Protein AQP1 Expression as Predictive Markers of Chemo-Resistance in Ovarian High-Grade Serous Carcinoma: Comparative Study between Preoperative Peritoneal Biopsies and Surgical Samples
    Giuseppe Angelico et al, 2021, Diagnostics CrossRef
  21. Synergistic effects of green tea extract and paclitaxel in the induction of mitochondrial apoptosis in ovarian cancer cell lines
    Mohammad Panji et al, 2021, Gene CrossRef
  22. Knockdown of Circular RNA Hsa_circ_0000714 Can Regulate RAB17 by Sponging miR-370-3p to Reduce Paclitaxel Resistance of Ovarian Cancer Through CDK6/RB Pathway
    Min Guo et al, 2020, OncoTargets and Therapy CrossRef